CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Clinical utilization of four-factor prothrombin complex concentrate: a retrospective single center study

Zaina Naeem, Salsabeel Allan, Aneury Hernandez, Dennis K Galanakis, Adam J. Singer

Clin Exp Emerg Med. 2021;8(2):75-81. Published online 2021 June 30 DOI: https://doi.org/10.15441/ceem.20.017

Clinical utilization of four-factor prothrombin complex concentrate: a retrospective single center study

Zaina Naeem, Salsabeel Allan, Aneury Hernandez, Dennis K Galanakis, Adam J. Singer

Clinical and Experimental Emergency Medicine. 2021;8(2):75-81

Link1

Link2 Link3

Propensity Score Adjusted Comparison of Three-Factor versus Four-Factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal: A Retrospective Cohort Study

David Margraf, Scott Seaburg, Gregory Beilman, Julian Wolfson, Jonathan Gipson, Scott A Chapman

. 2020;

Link1 Link2

The outcome of three-factor Prothrombin Complex Concentrate (3F-PCC) in warfarin reversal: A single center retrospective cohort study

Hock Peng Koh, Nirmala Jagan, Szu Lynn Tay, Jivanraj Nagarajah, Noel Thomas Ross

Thrombosis Update. 2020;1:100014

Link1 Link2

THE USE OF FOUR FACTOR PROTHROMBIN COMPLEX CONCENTRATE (KCENTRA) IN PATIENTS WITH LIVER FAILURE: RETROSPECTIVE STUDY OF SAFETY AND EFFICACY

Irina Khachatryan, Amy Ives, Sharon O'Brien

Chest. 2020;158(4):A2487

Link1 Link2

A Tertiary Academic Medical Center Blood Bank’s Experience With Four-Factor Prothrombin Complex Concentrate

Aaron D Shmookler, Tracie L Nichols, Peter L Perrotta

American Journal of Clinical Pathology. 2021;156(2):246-252

Link1

Link2

More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate

Tomas L. Lindahl, Maria Wallstedt, Kerstin M. Gustafsson, Egon Persson, Andreas Hillarp

Thrombosis Research. 2015;135(3):544-547

Link1 Link2

Four-factor prothrombin complex concentrate use for on-label versus off-label indications: a retrospective cohort study

Brian D. Adkins, Hila Shaim, Abdul Abid, Adam Gonzalez, Abe DeAnda, Sean G. Yates

Journal of Thrombosis and Thrombolysis. 2022;

Link1

Link2 Link3

Propensity score adjusted comparison of three-factor versus four-factor prothrombin complex concentrate for emergent warfarin reversal: a retrospective cohort study

David J. Margraf, Scott Seaburg, Gregory J. Beilman, Julian Wolfson, Jonathan C. Gipson, Scott A. Chapman

BMC Emergency Medicine. 2020;20(1):

Link1

Link2 Link3

Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation

Jonathan H. Sin, Karen Berger, Christine A. Lesch

Journal of Critical Care. 2016;36:166-172

Link1 Link2

Association of four‐factor prothrombin complex concentrate with subsequent plasma transfusion: A retrospective cohort study

Sammie J. Roberts, Paul Pokrandt, Elizabeth Jewell, Milo Engoren, Mary P. Berg, Michael D. Maile

Transfusion Medicine. 2020;31(1):69-75

Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Exp Emerg Med has participated in CrossRef Text and Data Mining service since October 29, 2014.